Rici Healthcare Holdings Limited
Sembol: 1526.HK
HKSE
1.15
HKDBugünkü piyasa fiyatı
4.4392
F/K Oranı
-0.0263
PEG Oranı
1.83B
MRK Kapağı
- 0.13%
DIV Verimi
Rici Healthcare Holdings Limited (1526-HK) Finansal Tablolar
Bilanço
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 811.2 | 720.1 | 784.4 | |||||||||||
balance-sheet.row.short-term-investments | 0 | 11.9 | 0 | 13.1 | |||||||||||
balance-sheet.row.net-receivables | 0 | 299.5 | 278.7 | 346.7 | |||||||||||
balance-sheet.row.inventory | 0 | 37.4 | 56 | 61.7 | |||||||||||
balance-sheet.row.other-current-assets | 0 | 270 | 301.4 | 249 | |||||||||||
balance-sheet.row.total-current-assets | 0 | 1438.6 | 1356.3 | 1441.7 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2824.9 | 2664.1 | 2774.3 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 20.7 | 5.4 | 10.9 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 20.7 | 5.4 | 10.9 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 193.7 | 192.3 | 10.2 | |||||||||||
balance-sheet.row.tax-assets | 0 | 109.9 | 124.8 | 213.5 | |||||||||||
balance-sheet.row.other-non-current-assets | 0 | 50 | -124.8 | -213.5 | |||||||||||
balance-sheet.row.total-non-current-assets | 0 | 3199.2 | 2861.8 | 2795.3 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 348.7 | 299.1 | |||||||||||
balance-sheet.row.total-assets | 0 | 4637.8 | 4566.9 | 4536.2 | |||||||||||
balance-sheet.row.account-payables | 0 | 164.4 | 171 | 189.3 | |||||||||||
balance-sheet.row.short-term-debt | 0 | 911.8 | 880.7 | 1064.2 | |||||||||||
balance-sheet.row.tax-payables | 0 | 114.3 | 72.4 | 64.7 | |||||||||||
balance-sheet.row.long-term-debt-total | 0 | 1354.8 | 320.2 | 474.7 | |||||||||||
Deferred Revenue Non Current | 0 | 3.7 | 90.3 | 94.1 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 0 | 1353.3 | 1982.9 | 1840.8 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 1358.5 | 320.2 | 474.7 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 1188 | 1444 | |||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1399.9 | 1363.2 | 1494.4 | |||||||||||
balance-sheet.row.total-liab | 0 | 3523.7 | 3662 | 3948.8 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 220.8 | 206.4 | |||||||||||
balance-sheet.row.common-stock | 0 | 1.1 | 1.1 | 1.1 | |||||||||||
balance-sheet.row.retained-earnings | 0 | 517.4 | 458.3 | 167.6 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1125.9 | -220.8 | -206.4 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -517.4 | 494.5 | 508.9 | |||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1126.9 | 953.9 | 677.5 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4637.8 | 4566.9 | 4536.2 | |||||||||||
balance-sheet.row.minority-interest | 0 | -12.9 | -49.1 | -90.1 | |||||||||||
balance-sheet.row.total-equity | 0 | 1114 | 904.8 | 587.4 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||
Total Investments | 0 | 193.7 | 192.3 | 23.3 | |||||||||||
balance-sheet.row.total-debt | 0 | 2266.6 | 2298.6 | 2743.3 | |||||||||||
balance-sheet.row.net-debt | 0 | 1455.3 | 1578.4 | 1972 |
Nakit Akış Tablosu
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 363.8 | 290.8 | 181.6 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 356.7 | 367.8 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 43.6 | 69.4 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | -3.2 | 10.9 | 16.9 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -54.5 | -86.2 | |||||||||||
cash-flows.row.account-receivables | 0 | 0 | -63.8 | -78.9 | |||||||||||
cash-flows.row.inventory | 0 | 0 | 9.2 | -7.3 | |||||||||||
cash-flows.row.account-payables | 0 | 0 | 4.7 | 4.8 | |||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | -360.6 | 58.9 | 131.8 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -310 | -324.7 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 128 | 0 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -180 | 0 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 52 | 0 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 36.1 | 55.5 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -274 | -269.1 | |||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -1763.7 | -1052.3 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 1268.5 | 858.3 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | -495.2 | -194 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 11.7 | -8.5 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | -51.1 | 209.4 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 720.1 | 720.1 | 771.3 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 720.1 | 771.3 | 561.8 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 706.4 | 681.1 | |||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -310 | -324.7 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 396.3 | 356.4 |
Gelir Tablosu Satırı
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 2992.7 | 2375 | 2377.2 | |||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1743.2 | 1447.8 | 1402 | |||||||||||
income-statement-row.row.gross-profit | 0 | 1249.5 | 927.2 | 975.2 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 7.4 | -3.2 | 11.3 | |||||||||||
income-statement-row.row.operating-expenses | 0 | 590.3 | 483.4 | 466.5 | |||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2333.5 | 1931.2 | 1868.5 | |||||||||||
income-statement-row.row.interest-income | 0 | 10.4 | 116.6 | 116.6 | |||||||||||
income-statement-row.row.interest-expense | 0 | 127.1 | 123.1 | 123.5 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -111.3 | -104.8 | -128.6 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 7.4 | -3.2 | 11.3 | |||||||||||
income-statement-row.row.total-operating-expenses | 0 | -111.3 | -104.8 | -128.6 | |||||||||||
income-statement-row.row.interest-expense | 0 | 127.1 | 123.1 | 123.5 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 396.8 | 140.7 | 162.1 | |||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 0 | 656.9 | 431.9 | 520.7 | |||||||||||
income-statement-row.row.income-before-tax | 0 | 545.6 | 327.2 | 392.1 | |||||||||||
income-statement-row.row.income-tax-expense | 0 | 143.7 | 84 | 98.4 | |||||||||||
income-statement-row.row.net-income | 0 | 363.8 | 290.8 | 349.1 |
Sıkça Sorulan Sorular
Nedir Rici Healthcare Holdings Limited (1526.HK) toplam varlıklar?
Rici Healthcare Holdings Limited (1526.HK) toplam varlıklar 4637755000.000 şeklindedir.
İşletmenin yıllık geliri nedir?
Yıllık gelir N/A'dur.
Firma kâr marjı nedir?
Firma kar marjı 0.418'dir.
Şirket serbest nakit akışı nedir?
Serbest nakit akışı 0.306'dur.
İşletme net kar marjı nedir?
Net kâr marjı 0.122'dir.
Firma toplam geliri nedir?
Toplam gelir 0.220'dur.
Nedir Rici Healthcare Holdings Limited (1526.HK) net kar (net gelir)?
Net kar (net gelir) 363803000.000'dur.
Firmanın toplam borcu nedir?
Toplam borç 2266551000.000'dir.
Faaliyet giderleri rakamı nedir?
İşletme giderleri 590326000.000'dır.
Şirket nakit rakamı nedir?
İşletme içi nakit 0.000'tir.